Prof. Michael Sela serves as the Chairman of Pontifax Ltd. Prof. Sela has been a Member of Scientific Advisory Board at Evotec (Göttingen) AG (formerly DeveloGen AG) since June 1, 2005. He serves as a Member of Scientific Advisory Board at Rosetta Genomics. He served as a Director of Teva Pharmaceutical Industries Ltd. since 1987. He served as a Director of Yeda Research and Development Co. Ltd. Prof. Sela served as the President of the Weizmann Institute of Science in Rehovot, Israel, and Chief Immunologist at the New England Medical Center in Boston, USA.